Matches in SemOpenAlex for { <https://semopenalex.org/work/W1639772019> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W1639772019 endingPage "67" @default.
- W1639772019 startingPage "457" @default.
- W1639772019 abstract "It has been suggested that erythma nodosum leprosum (ENL) is associated with enhanced production of TNF-alpha resulting in increased inflammation of the skin and nerve function impairment. Thalidomide and steroids are the major drugs used in the treatment of ENL, but due to the serious problems associated with their use, alternative therapeutic interventions are being considered. In the present retrospective study, the authors report their clinical observations on the effect of pentoxifylline (PTX) in the treatment of ENL. Parameters, such as the clinical involution of reactional lesions, the regression of the inflammatory symptoms associated with the lesions, and the impact on the systemic symptoms common to ENL were assessed at regular intervals during PTX therapy. It was found that PTX therapy led to total elimination of systemic symptoms within the first week of treatment. This improvement was maintained until the end of the study (60 days of treatment). Moreover, the evolution of nodular lesions showed a 100% improvement within the first 14 days of treatment. However, by the 60th day, worsening of the lesions was noted in 20% of the cases. The impression is that PTX is well tolerated, and it may be used for improving patient's clinical condition during ENL reaction. Nevertheless, a randomized, double blind, controlled trial to compare the effects of the widely-accepted thalidomide and the yet untested pentoxifylline for treatment of type 2 reaction is still necessary." @default.
- W1639772019 created "2016-06-24" @default.
- W1639772019 creator A5020274870 @default.
- W1639772019 creator A5036548831 @default.
- W1639772019 creator A5040190247 @default.
- W1639772019 creator A5047964295 @default.
- W1639772019 creator A5048740941 @default.
- W1639772019 creator A5059058852 @default.
- W1639772019 creator A5061482275 @default.
- W1639772019 date "2001-02-24" @default.
- W1639772019 modified "2023-10-16" @default.
- W1639772019 title "The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy." @default.
- W1639772019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11212480" @default.
- W1639772019 hasPublicationYear "2001" @default.
- W1639772019 type Work @default.
- W1639772019 sameAs 1639772019 @default.
- W1639772019 citedByCount "7" @default.
- W1639772019 countsByYear W16397720192014 @default.
- W1639772019 countsByYear W16397720192018 @default.
- W1639772019 countsByYear W16397720192020 @default.
- W1639772019 crossrefType "journal-article" @default.
- W1639772019 hasAuthorship W1639772019A5020274870 @default.
- W1639772019 hasAuthorship W1639772019A5036548831 @default.
- W1639772019 hasAuthorship W1639772019A5040190247 @default.
- W1639772019 hasAuthorship W1639772019A5047964295 @default.
- W1639772019 hasAuthorship W1639772019A5048740941 @default.
- W1639772019 hasAuthorship W1639772019A5059058852 @default.
- W1639772019 hasAuthorship W1639772019A5061482275 @default.
- W1639772019 hasConcept C126322002 @default.
- W1639772019 hasConcept C141071460 @default.
- W1639772019 hasConcept C16005928 @default.
- W1639772019 hasConcept C168563851 @default.
- W1639772019 hasConcept C2776364478 @default.
- W1639772019 hasConcept C2777410594 @default.
- W1639772019 hasConcept C2779134260 @default.
- W1639772019 hasConcept C2779609412 @default.
- W1639772019 hasConcept C2780404050 @default.
- W1639772019 hasConcept C2780695269 @default.
- W1639772019 hasConcept C535046627 @default.
- W1639772019 hasConcept C71924100 @default.
- W1639772019 hasConcept C90924648 @default.
- W1639772019 hasConceptScore W1639772019C126322002 @default.
- W1639772019 hasConceptScore W1639772019C141071460 @default.
- W1639772019 hasConceptScore W1639772019C16005928 @default.
- W1639772019 hasConceptScore W1639772019C168563851 @default.
- W1639772019 hasConceptScore W1639772019C2776364478 @default.
- W1639772019 hasConceptScore W1639772019C2777410594 @default.
- W1639772019 hasConceptScore W1639772019C2779134260 @default.
- W1639772019 hasConceptScore W1639772019C2779609412 @default.
- W1639772019 hasConceptScore W1639772019C2780404050 @default.
- W1639772019 hasConceptScore W1639772019C2780695269 @default.
- W1639772019 hasConceptScore W1639772019C535046627 @default.
- W1639772019 hasConceptScore W1639772019C71924100 @default.
- W1639772019 hasConceptScore W1639772019C90924648 @default.
- W1639772019 hasIssue "4" @default.
- W1639772019 hasLocation W16397720191 @default.
- W1639772019 hasOpenAccess W1639772019 @default.
- W1639772019 hasPrimaryLocation W16397720191 @default.
- W1639772019 hasRelatedWork W1579019043 @default.
- W1639772019 hasRelatedWork W1592233687 @default.
- W1639772019 hasRelatedWork W1639772019 @default.
- W1639772019 hasRelatedWork W2009157209 @default.
- W1639772019 hasRelatedWork W2120825367 @default.
- W1639772019 hasRelatedWork W22738833 @default.
- W1639772019 hasRelatedWork W23182260 @default.
- W1639772019 hasRelatedWork W2432412368 @default.
- W1639772019 hasRelatedWork W2790352162 @default.
- W1639772019 hasRelatedWork W4255245686 @default.
- W1639772019 hasVolume "72" @default.
- W1639772019 isParatext "false" @default.
- W1639772019 isRetracted "false" @default.
- W1639772019 magId "1639772019" @default.
- W1639772019 workType "article" @default.